Literature DB >> 26253710

Seasonal variations in vitamin D in relation to growth in short prepubertal children before and during first year growth hormone treatment.

B Andersson1, D Swolin-Eide2, B Kriström3, L Gelander2,4, P Magnusson5, K Albertsson-Wikland6.   

Abstract

PURPOSE: This study investigated the relationship between seasonal variations in 25-hydroxyvitamin D (25(OH)D) levels and growth in prepubertal children during both the pretreatment year and the first year of GH treatment.
METHODS: The study included 249 short prepubertal children with a broad range of GH secretion, GH(max) during a 24 h profile median 23; range 1-127 mU/L, 191 boys (mean age ± SD, 8.6 ± 2.6 years), 58 girls (7.5 ± 1.9 years) receiving GH treatment (mean 43 µg/kg/day; range 17-99 µg/kg/day). Serum 25(OH)D was measured using an automated IDS-iSYS immunoassay.
RESULTS: 25(OH)D levels showed seasonal variation, and decreased significantly during GH treatment. 25(OH)D levels at start and first year reduction in 25(OH)D, correlated (-) with the first year growth response during treatment. The degree of GH secretion capacity within our study population of mainly non-GH deficient children and 25(OH)D sufficient (67 ± 29 nmol/L) had no influence on 25(OH)D levels. Growth during GH treatment were independent of seasonal variations in 25(OH)D. Multiple regression analysis showed that 25(OH)D levels at treatment start, together with auxological data and IGF-binding protein-(3)SDS, explained 61 % of the variation in first year gain in heightSDS.
CONCLUSION: 25(OH)D levels were associated with first year growth response to GH and may be a useful contribution to future growth prediction models.

Entities:  

Keywords:  25-Hydroxyvitamin D; Growth hormone; Growth response

Mesh:

Substances:

Year:  2015        PMID: 26253710     DOI: 10.1007/s40618-015-0360-1

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  42 in total

1.  Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities.

Authors:  K A Wikland; B Kriström; S Rosberg; B Svensson; A F Nierop
Journal:  Pediatr Res       Date:  2000-10       Impact factor: 3.756

2.  25-hydroxyvitamin D serum level in children of different ethnicity living in Italy.

Authors:  Bruna Franchi; Michele Piazza; Marco Sandri; Laura Tenero; Pasquale Comberiati; Attilio Loris Boner; Carlo Capristo
Journal:  Eur J Pediatr       Date:  2014-11-15       Impact factor: 3.183

3.  Vitamin D status: sunshine is nice but other factors prevail.

Authors:  Göran Toss; Per Magnusson
Journal:  Eur J Nutr       Date:  2012-02-03       Impact factor: 5.614

Review 4.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

5.  1,25(OH)2D3 receptor regulation and 1,25(OH)2D3 effects in primary cultures of growth cartilage cells of the rat.

Authors:  G Klaus; J Merke; H Eing; U Hügel; P Milde; H Reichel; E Ritz; O Mehls
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

6.  Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro.

Authors:  Z Schwartz; D L Schlader; V Ramirez; M B Kennedy; B D Boyan
Journal:  J Bone Miner Res       Date:  1989-04       Impact factor: 6.741

7.  Seasonality of growth response to GH therapy in prepubertal children with idiopathic growth hormone deficiency.

Authors:  C Land; W F Blum; A Stabrey; E Schoenau
Journal:  Eur J Endocrinol       Date:  2005-05       Impact factor: 6.664

8.  Analyses of 24-hour growth hormone profiles in children: relation to growth.

Authors:  K Albertsson-Wikland; S Rosberg
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

9.  Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort.

Authors:  Dana Bailey; David Colantonio; Lianna Kyriakopoulou; Ashley H Cohen; Man Khun Chan; David Armbruster; Khosrow Adeli
Journal:  Clin Chem       Date:  2013-05-01       Impact factor: 8.327

10.  Is there "seasonal" variation in height velocity in children treated with growth hormone? Data from the National Cooperative Growth Study.

Authors:  Dorothy I Shulman; James Frane; Barbara Lippe
Journal:  Int J Pediatr Endocrinol       Date:  2013-02-02
View more
  3 in total

1.  Vitamin D and Parathyroid Hormone during Growth Hormone Treatment.

Authors:  Teodoro Durá-Travé; Fidel Gallinas-Victoriano
Journal:  Children (Basel)       Date:  2022-05-15

2.  Serum 25-hydroxyvitamin D status among Saudi children with and without a history of fracture.

Authors:  N M Al-Daghri; N Aljohani; S Rahman; S Sabico; O S Al-Attas; M S Alokail; A Al-Ajlan; G P Chrousos
Journal:  J Endocrinol Invest       Date:  2016-06-16       Impact factor: 4.256

Review 3.  Vitamin D and growth hormone in children: a review of the current scientific knowledge.

Authors:  Susanna Esposito; Alberto Leonardi; Lucia Lanciotti; Marta Cofini; Giulia Muzi; Laura Penta
Journal:  J Transl Med       Date:  2019-03-18       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.